Ay, France

Philippe Collery

This inventor holds 1 USPTO granted patent. Top assignee: Les Laboratoires Meram. Active years: 1986.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Philippe Collery. Retrieved from https://idiyas.com/inventor/philippe-collery-0rj61n5p

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 1.0

ph-index = 1

Forward Citations = 13(Granted Patents)


Company Filing History:


Years Active: 1986

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Philippe Collery: Innovator in Anti-Cancer Drug Development

Introduction

Philippe Collery is a notable inventor based in Ay, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-cancer treatments. His innovative approach has the potential to impact the lives of many patients suffering from malignant tumors.

Latest Patents

Collery holds a patent for his invention titled "Gallium chloride as a new anti-cancerous drug." This patent relates to the application of gallium chloride as a drug particularly useful for the treatment of malignant tumors. The pharmaceutical compositions he developed are intended for oral administration and contain from 100 to 500 mg of active ingredient per unit dose. This invention represents a promising advancement in cancer treatment.

Career Highlights

Philippe Collery is associated with Les Laboratoires Meram, where he continues to work on innovative pharmaceutical solutions. His dedication to research and development has led to the creation of effective treatments that address critical health challenges.

Conclusion

Philippe Collery's work in the field of anti-cancer drug development exemplifies the impact of innovation in medicine. His contributions are paving the way for new treatment options that could benefit countless individuals facing cancer.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…